Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H19N3O4S |
| Molecular Weight | 361.415 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(NC(=N2)S(=O)(=O)CC3=NC=C(C)C(OC)=C3C)C=C1
InChI
InChIKey=IXEQEYRTSRFZEO-UHFFFAOYSA-N
InChI=1S/C17H19N3O4S/c1-10-8-18-15(11(2)16(10)24-4)9-25(21,22)17-19-13-6-5-12(23-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)
Omeprazole sulfone is the major metabolite of the omeprazole, gastric proton pump inhibitor. Metabolite is formed by the sulfoxidation of the omeprazole under the action of cytochrome P450 (CYP)3A4. Omeprazole sulfone is found in plasma and shows elimination rate–limited kinetics in vivo. Omeprazole sulfone has been shown to act as a reversible direct-acting and metabolism-dependent inhibitor of CYP2C19.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
88546-55-8
Created by
admin on Mon Mar 31 19:52:26 GMT 2025 , Edited by admin on Mon Mar 31 19:52:26 GMT 2025
|
PRIMARY | |||
|
DTXSID40237116
Created by
admin on Mon Mar 31 19:52:26 GMT 2025 , Edited by admin on Mon Mar 31 19:52:26 GMT 2025
|
PRIMARY | |||
|
1478516
Created by
admin on Mon Mar 31 19:52:26 GMT 2025 , Edited by admin on Mon Mar 31 19:52:26 GMT 2025
|
PRIMARY | |||
|
145900
Created by
admin on Mon Mar 31 19:52:26 GMT 2025 , Edited by admin on Mon Mar 31 19:52:26 GMT 2025
|
PRIMARY | |||
|
76X040Z74O
Created by
admin on Mon Mar 31 19:52:26 GMT 2025 , Edited by admin on Mon Mar 31 19:52:26 GMT 2025
|
PRIMARY |
PARENT (METABOLITE INACTIVE)
PARENT (METABOLITE INACTIVE)
SUBSTANCE RECORD
